Events & Presentations
| Upcoming Event | |||
|---|---|---|---|
|
9:00 AM ET |
UBS Global Healthcare Conference
Speaker: Dan Spiegelman, Chief Financial Officer
|
||
| Archived Events | |||
|---|---|---|---|
|
9:45 AM CT |
Baird Growth Stock Conference
Speaker: Dan Maher, Senior Vice President of Product Development
|
||
|
5:00 PM ET |
BioMarin Pharmaceutical Inc. First Quarter 2013 Financial Results Conference Call
|
||
|
5:00 PM ET |
BioMarin Pharmaceutical BMN-701 Phase 1/2 Trial Results Conference Call
|
||
|
8:30 AM ET |
Barclays Global Healthcare Conference
Speaker: Joshua Grass, Senior Vice President of Corporate and Business Development |
||
|
|
Credit Suisse Global Healthcare Conference
|
||
|
4:50 PM ET |
Cowen Healthcare Conference i
Speaker: Dan Maher, Senior Vice President of Corporate and Business Development |
||
|
1:35 PM ET |
RBC 2013 Healthcare Conference
Speaker: Dan Spiegelman, Chief Financial Officer
|
||
|
|
Citibank Global Healthcare Conference
|
||
|
|
Canaccord Genuity Orphan Drug Day
|
||
|
5:00 PM ET |
BioMarin Pharmaceutical Inc. Fourth Quarter and Full Year 2012 Financial Results Conference Call
|
||
|
3:30 PM ET |
BIO CEO & Investor Conference
Speaker: Jean-Jacques Bienaimé, Chief Executive Officer
|
||
|
10:30 AM PT |
J.P. Morgan Healthcare Conference
Speaker: Jean-Jacques Bienaimé, Chief Executive Officer
|
||
|
8:00 AM ET |
BioMarin Pharmaceuticals' R&D Day
|
||
|
9:35 AM ET |
Deutsche Bank BioFEST Conference
Speaker: Dan Spiegelman, Chief Financial Officer
|
||
|
9:00 AM ET |
Piper Jaffray Health Care Conference 2012
Speaker: Joshua Grass, Senior Vice President of Corporate and Business Development
|
||
|
10:00 AM MT |
Credit Suisse Healthcare Conference
Speaker: Dan Maher, Senior Vice President of Product Development
|
||
|
4:00 PM ET |
Lazard Capital Markets Healthcare Conference
Speaker: Jean-Jacques Bienaimé, Chief Executive Officer
|
||
|
8:30 AM ET |
BioMarin Pharmaceutical Inc. GALNS Phase 3 Results Conference Call
|
||
|
5:00 PM ET |
BioMarin Pharmaceutical Inc. Third Quarter 2012 Financial Results Conference Call
|
||
|
2:00 PM PT |
PEG-PAL Phase 2 and BMN-111 Phase 1 trials
|
||
|
5:00 PM |
Q2 2012 BioMarin Pharmaceutical Inc. Earnings Conference Call
|
||


= add file to Briefcase
